News > Latest News

Walk News | Sponsor & Foundation News | News in the Parkinson's Disease Community

News in the Parkinson's Disease Community

Cynapsus Therapeutics Parkinson’s Disease Candidate Gets FDA Fast Track Designation

New Test May Help Detect Parkinson’s Disease in Early Stages of Life

Simple Eye Test May Detect Parkinson’s Disease

Manufacturing Dopamine in the Brain with Gene Therapy

NeuroDerm Initiates Patient Enrollment in a Phase III Trial of ND0612L for the Treatment of PD

Researchers Examine How Parkinson’s Disease Alters Brain Activity Over Time

Leukemia Drug Proven Effective Against Parkinson’s Disease

Cynapsus Announces Publication of Data for the Treatment of OFF Episodes in Patients with PD

Parkinson’s: Mutant Enzyme, a-Synuclein Interaction May Be Preventable

National Parkinson Foundation (NPF) and the Parkinson's Disease Foundation (PDF) Complete Merger to Form the Parkinson's Foundation

Study Shows Cancer Drug Raises Dopamine Levels in Parkinson’s Patients

Parkinson's Disease Biomarker Found in Patient Urine Samples

Johns Hopkins Researchers Reveal Novel Protein and Involvement in Parkinson’s Disease

Scientists Offer New View on Origins of Parkinson's Disease

NeuroDerm Presents Three Posters at the 20th International Congress of Parkinson’s Disease and Movement Disorders

MS Drug Could Prove Effective Parkinson's Treatment

UCLA Scientists Discover Protective Strategy Against Pesticide-linked Parkinson’s Disease

New Gene Shown to Cause Parkinson's Disease

Great Lakes Neurotech Validation Studies on Wearable Tech for Parkinson’s to be Highlighted at International Conference

NeuroDerm Announces Patient Enrollment in Long-Term Safety Trial of ND0612 for PD

U.S. Approves First drug for Psychosis Linked to Parkinson's Disease

Adamas Pharma (ADMS) Announces ADS-5102 Phase 3 Met Primary, Key Secondary Endpoints as LID Treatment